[\'From the, Division of Inflammation and Infection, Department of Biomedical and Clinical Sciences, Faculty of Medicine and Health Sciences, Linköping University, Linköping, Sweden.\']
On the relationship between BCG coverage and national COVID-19 outcome: could \'heterologous\' herd immunity explain why some countries are better off?